These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8226604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Idiopathic blepharospasm-oromandibular dystonia syndrome (Meige's syndrome) presenting as chronic temporomandibular joint dislocation.
    Gray AR, Barker GR.
    Br J Oral Maxillofac Surg; 1991 Apr; 29(2):97-9. PubMed ID: 2049364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E, Martí MJ.
    Adv Neurol; 1988 Apr; 49():73-84. PubMed ID: 3278555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Posterior laryngeal stenosis in patient with Meige's Syndrome].
    Pino Rivero V, Marcos García M, Trinidad Ruíz G, Pardo Romero G, González Palomino A, Blasco Huelva A.
    An Otorrinolaringol Ibero Am; 2004 Apr; 31(4):349-54. PubMed ID: 15382486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters.
    Nutt JG, Hammerstad JP.
    Ann Neurol; 1981 Feb; 9(2):189-91. PubMed ID: 7235635
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meige's syndrome associated with neuroleptic treatment.
    Ananth J, Edelmuth E, Dargan B.
    Am J Psychiatry; 1988 Apr; 145(4):513-5. PubMed ID: 2894781
    [Abstract] [Full Text] [Related]

  • 15. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC.
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [Abstract] [Full Text] [Related]

  • 16. Neuroleptic-induced Meige's syndrome following akathisia: pharmacologic characteristics.
    Hayashi T, Furutani M, Taniyama J, Kiyasu M, Hikasa S, Horiguchi J, Yamawaki S.
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):445-8. PubMed ID: 9766696
    [Abstract] [Full Text] [Related]

  • 17. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
    Dresel C, Haslinger B, Castrop F, Wohlschlaeger AM, Ceballos-Baumann AO.
    Brain; 2006 Jan; 129(Pt 1):36-46. PubMed ID: 16280353
    [Abstract] [Full Text] [Related]

  • 18. Therapy-refractory schizophrenia in a patient who previously suffered from Meige's syndrome.
    Uemura T, Mochida M, Matsumi T, Yoshimoto K, Tatebayashi Y.
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):297-300. PubMed ID: 31743613
    [Abstract] [Full Text] [Related]

  • 19. Meige's Syndrome: Rare Neurological Disorder Presenting as Conversion Disorder.
    Debadatta M, Mishra AK.
    Indian J Psychol Med; 2013 Jul; 35(3):317-8. PubMed ID: 24249940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.